174 related articles for article (PubMed ID: 18537201)
1. Synthesis of benzamides related to anacardic acid and their histone acetyltransferase (HAT) inhibitory activities.
Souto JA; Conte M; Alvarez R; Nebbioso A; Carafa V; Altucci L; de Lera AR
ChemMedChem; 2008 Sep; 3(9):1435-42. PubMed ID: 18537201
[TBL] [Abstract][Full Text] [Related]
2. New anacardic acid-inspired benzamides: histone lysine acetyltransferase activators.
Souto JA; Benedetti R; Otto K; Miceli M; Alvarez R; Altucci L; de Lera AR
ChemMedChem; 2010 Sep; 5(9):1530-40. PubMed ID: 20683922
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of benzamide derivatives of anacardic acid and their cytotoxic activity.
Chandregowda V; Kush A; Reddy GC
Eur J Med Chem; 2009 Jun; 44(6):2711-9. PubMed ID: 19246131
[TBL] [Abstract][Full Text] [Related]
4. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative.
Ghizzoni M; Boltjes A; Graaf Cd; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2010 Aug; 18(16):5826-34. PubMed ID: 20655754
[TBL] [Abstract][Full Text] [Related]
5. Activation of p300 histone acetyltransferase by small molecules altering enzyme structure: probed by surface-enhanced Raman spectroscopy.
Mantelingu K; Kishore AH; Balasubramanyam K; Kumar GV; Altaf M; Swamy SN; Selvi R; Das C; Narayana C; Rangappa KS; Kundu TK
J Phys Chem B; 2007 May; 111(17):4527-34. PubMed ID: 17417897
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule inhibitors of histone acetyltransferase activity: identification and biological properties.
Mai A; Rotili D; Tarantino D; Ornaghi P; Tosi F; Vicidomini C; Sbardella G; Nebbioso A; Miceli M; Altucci L; Filetici P
J Med Chem; 2006 Nov; 49(23):6897-907. PubMed ID: 17154519
[TBL] [Abstract][Full Text] [Related]
7. Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases.
Mai A; Rotili D; Tarantino D; Nebbioso A; Castellano S; Sbardella G; Tini M; Altucci L
Bioorg Med Chem Lett; 2009 Feb; 19(4):1132-5. PubMed ID: 19144517
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs).
Gorsuch S; Bavetsias V; Rowlands MG; Aherne GW; Workman P; Jarman M; McDonald E
Bioorg Med Chem; 2009 Jan; 17(2):467-74. PubMed ID: 19101154
[TBL] [Abstract][Full Text] [Related]
9. Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases.
Sbardella G; Castellano S; Vicidomini C; Rotili D; Nebbioso A; Miceli M; Altucci L; Mai A
Bioorg Med Chem Lett; 2008 May; 18(9):2788-92. PubMed ID: 18434144
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors.
Kim DK; Lee JY; Kim JS; Ryu JH; Choi JY; Lee JW; Im GJ; Kim TK; Seo JW; Park HJ; Yoo J; Park JH; Kim TY; Bang YJ
J Med Chem; 2003 Dec; 46(26):5745-51. PubMed ID: 14667227
[TBL] [Abstract][Full Text] [Related]
11. Small molecule modulators of histone acetyltransferase p300.
Balasubramanyam K; Swaminathan V; Ranganathan A; Kundu TK
J Biol Chem; 2003 May; 278(21):19134-40. PubMed ID: 12624111
[TBL] [Abstract][Full Text] [Related]
12. Omega-alkoxy analogues of SAHA (vorinostat) as inhibitors of HDAC: a study of chain-length and stereochemical dependence.
Hanessian S; Auzzas L; Giannini G; Marzi M; Cabri W; Barbarino M; Vesci L; Pisano C
Bioorg Med Chem Lett; 2007 Nov; 17(22):6261-5. PubMed ID: 17892933
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group.
Chen PC; Patil V; Guerrant W; Green P; Oyelere AK
Bioorg Med Chem; 2008 May; 16(9):4839-53. PubMed ID: 18397827
[TBL] [Abstract][Full Text] [Related]
14. Characterization of novel inhibitors of histone acetyltransferases.
Eliseeva ED; Valkov V; Jung M; Jung MO
Mol Cancer Ther; 2007 Sep; 6(9):2391-8. PubMed ID: 17876038
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
Rahim R; Strobl JS
Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
[TBL] [Abstract][Full Text] [Related]
16. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
Sagar V; Zheng W; Thompson PR; Cole PA
Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of 4-[(s-triazin-2-ylamino)methyl]-N-(2-aminophenyl)-benzamides and their analogues as a novel class of histone deacetylase inhibitors.
Paquin I; Raeppel S; Leit S; Gaudette F; Zhou N; Moradei O; Saavedra O; Bernstein N; Raeppel F; Bouchain G; Fréchette S; Woo SH; Vaisburg A; Fournel M; Kalita A; Robert MF; Lu A; Trachy-Bourget MC; Yan PT; Liu J; Rahil J; MacLeod AR; Besterman JM; Li Z; Delorme D
Bioorg Med Chem Lett; 2008 Feb; 18(3):1067-71. PubMed ID: 18160287
[TBL] [Abstract][Full Text] [Related]
18. epigenetic multiple ligands: mixed histone/protein methyltransferase, acetyltransferase, and class III deacetylase (sirtuin) inhibitors.
Mai A; Cheng D; Bedford MT; Valente S; Nebbioso A; Perrone A; Brosch G; Sbardella G; De Bellis F; Miceli M; Altucci L
J Med Chem; 2008 Apr; 51(7):2279-90. PubMed ID: 18348515
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and preliminary biological evaluation of new hydroxamate histone deacetylase inhibitors as potential antileukemic agents.
Guandalini L; Cellai C; Laurenzana A; Scapecchi S; Paoletti F; Romanelli MN
Bioorg Med Chem Lett; 2008 Sep; 18(18):5071-4. PubMed ID: 18723349
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of thiobenzanilides as anticancer agents.
Hu WP; Yu HS; Chen YR; Tsai YM; Chen YK; Liao CC; Chang LS; Wang JJ
Bioorg Med Chem; 2008 May; 16(9):5295-302. PubMed ID: 18359635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
